Back

Monocyte and endothelial dysfunction induced by hyperglycemia is reversed by Empagliflozin mainly through glucose-transport independent mechanisms

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Metabolic syndrome and vascular dysfunction Vascular Diseases ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Dilvin Semo

University Hospital of Munster, Munster (Germany)

5 More presentations in this session

Presentation thumbnail
Endothelial-specific deletion of methyltransferase Set7 protects mice from obesity-induced endothelial dysfunction
Doctor J. Sanchez Ceinos (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Targeting Neurofibromin 2 (NF2) Prevents Endothelial Dysfunction in Obesity: A Study in Mice and Humans
Doctor S. Mohammed (Zurich, CH)
Abstract Slides
Presentation thumbnail
Adverse epigenetic signatures driven by histone methyltransferase EZH2 contribute to hyperglycaemia-induced endothelial dysfunction
Doctor J. Sanchez Ceinos (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Impact of metabolic substrate modification on myocardial efficiency in a rat model of obesity and diabetes
Miss J. Virta (Turku, FI)
Abstract Slides
Presentation thumbnail
Endothelial retargeting of AAV9 in vivo
Doctor T. Bozoglu (Munich, DE)
Abstract Slides

Access the full session

Session thumbnail
Metabolic syndrome and vascular dysfunction

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Basic science
thumbnail
Congress Presentation
Preclinical and translational studies in Circulation
thumbnail
Congress Presentation
Preclinical heart failure in Circulation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources